iTonic Holdings Ltd
ITOC Nasdaq Electromedical & Electrotherapeutic Apparatus Financials FY2022โFY2025
What iTonic Holdings Ltd does
No business description yet.
- Legal name
- iTonic Holdings Ltd
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F ยท Mar 30, 2026
- Accession ยท CIK
- 0001213900-26-036395
0001970544
Revenue and margins
iTonic Holdings Ltd had $0.5M of revenue in fiscal 2025, up 16.7% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was โ$3.2M in fiscal 2025, โ618.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
iTonic Holdings Ltd returned $0.0M to shareholders in fiscal 2025. The diluted share count rose 26.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably iTonic Holdings Ltd can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Cash and short-term investments | $0.1M | $0.2M | $6.2M | $2.9M |
| Current ratio | โ | 0.4x | 12.4x | 8.8x |
| Quick ratio | โ | 0.4x | 12.2x | 8.7x |
| Total assets | โ | $1.6M | $6.7M | $9.1M |
| Total liabilities | โ | $1.3M | $0.5M | $1.0M |
| Shareholders' equity | $0.6M | $0.3M | $6.2M | $6.1M |
| Net debt (โ = net cash) | โ | โ | โ | โ |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ |
| F-score | โ / 3 | โ / 5 | 3 / 8 | 1 / 8 |
| Accruals ratio | โ | โ11.0% | 2.7% | โ23.6% |
| Altman Z'' | โ | โ3.48 | 17.02 | 3.40 |
4 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $0.7M | $0.6M | $0.4M | $0.5M |
| Gross profit | $0.6M | $0.5M | $0.4M | $0.3M |
| Research and development | $0.1M | $0.1M | $0.1M | $0.5M |
| Operating income | $0.0M | โ$0.3M | โ$0.8M | โ$5.2M |
| Pretax income | $0.1M | โ$0.3M | โ$0.6M | โ$5.1M |
| Income tax | โ$0.0M | โ$0.0M | $0.0M | โ |
| Net income | $0.1M | โ$0.2M | โ$0.7M | โ$5.1M |
| Diluted EPS | $0.01 | โ$0.02 | โ$0.05 | โ$0.32 |
| Diluted shares | 0.01B | 0.01B | 0.01B | 0.02B |
| Cash flow | ||||
| Cash from operations | โ$0.1M | โ$0.1M | โ$0.8M | โ$3.2M |
| Capital expenditure | โ | โ | $0.0M | $0.0M |
| Free cash flow | โ | โ | โ$0.8M | โ$3.2M |
| Stock-based compensation | โ | โ | โ | $2.9M |
| Dividends paid | $0.4M | โ | โ | $0.0M |
| Dividends and buybacks | $0.4M | โ | โ | $0.0M |
| Balance sheet | ||||
| Cash and short-term investments | $0.1M | $0.2M | $6.2M | $2.9M |
| Current assets | โ | $0.5M | $6.7M | $4.1M |
| Current liabilities | โ | $1.2M | $0.5M | $0.5M |
| Inventory | โ | $0.1M | $0.1M | $0.1M |
| Property and equipment, net | โ | $0.1M | $0.0M | $0.0M |
| Goodwill | โ | โ | โ | $2.0M |
| Intangible assets | โ | โ | โ | $2.4M |
| Total assets | โ | $1.6M | $6.7M | $9.1M |
| Total liabilities | โ | $1.3M | $0.5M | $1.0M |
| Shareholders' equity | $0.6M | $0.3M | $6.2M | $6.1M |
| Margins | ||||
| Gross margin | 82.1% | 74.9% | 85.1% | 62.6% |
| Operating margin | 4.0% | โ48.8% | โ171.9% | โ991.8% |
| Net margin | 12.4% | โ38.4% | โ147.4% | โ974.7% |
| FCF margin | โ | โ | โ173.1% | โ618.6% |
| Returns | ||||
| Return on capital employed | โ | โ74.6% | โ12.5% | โ60.1% |
| Return on equity | 15.1% | โ55.9% | โ20.4% | โ82.8% |
| Return on assets | โ | โ14.9% | โ15.8% | โ64.5% |
| Return on tangible equity | 15.1% | โ78.7% | โ10.7% | โ290.8% |
| Growth | ||||
| Revenue growth | โ | โ7.5% | โ28.7% | 16.7% |
| Net income growth | โ | โ387.1% | โ | โ |
| EPS growth | โ | โ385.7% | โ | โ |
| Share count change | โ | 0.0% | 6.0% | 26.1% |
| Financial health | ||||
| Current ratio | โ | 0.4x | 12.4x | 8.8x |
| Quick ratio | โ | 0.4x | 12.2x | 8.7x |
| Capital allocation | ||||
| Capex / revenue | โ | โ | 0.2% | 0.7% |
| Stock comp / revenue | โ | โ | โ | 563.2% |
| Quality scores | ||||
| Piotroski F-score | โ | โ | 3.0 | 1.0 |
| Altman Z'' | โ | โ3.5 | 17.0 | 3.4 |
| Accruals ratio | โ | โ11.0% | 2.7% | โ23.6% |
Source: SEC EDGAR XBRL filings (CIK 0001970544). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only โ not investment advice. Check the original filings before relying on any figure.